Opendata, web and dolomites

QRD SIGNED

A uniQue platform enabling faster development of treatments forRare Diseases

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 QRD project word cloud

Explore the words cloud of the QRD project. It provides you a very rough idea of what is the project "QRD" about.

rare    patient    bottleneck    pharma    drug    disease    cros    trial    recruitment    decodeon    clinical    time    inclusion    trials   

Project "QRD" data sheet

The following table provides information about the project.

Coordinator
DECODEON BV 

Organization address
address: BOOTHSTRAAT 5
city: UTRECHT
postcode: 3512 BT
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme /SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-01-01   to  2017-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DECODEON BV NL (UTRECHT) coordinator 50˙000.00

Mappa

 Project objective

Patient availability is one of the key elements associated with the successful execution of rare disease drug trials, and at the same time a major bottleneck that increases drug development time and cost. Patient recruitment is responsible for 25-30% of the total costs of a clinical trial, for adding substantially to the duration of a trial, and for the failure of 1 in 3 Phase 3 clinical trials. Decodeon aims to transform this bottleneck into a major node in the value chain by developing and deploying structured and efficient patient registries for pharma companies and Contract Research Organisations (CROs). In doing so, Decodeon aims to overhaul this major inefficiency in clinical trial management, while tapping into an unexplored market worth €2.5 billion. Currently, big pharma tenders clinical trials to CROs, who perform a trial for e.g. a lump sum. Decodeon will provide CROs with rare disease patients who have pre-consented with inclusion in a clinical trial, filtered based on the specific inclusion/exclusion criteria of the trial, and at the required numbers. As a consequence, CRO efficiency will increase, through lowering the time required for patient recruitment and the associated costs. Support for our novel platform is demonstrated through letters of support, annexed to this proposal.

 Work performed, outcomes and results:  advancements report(s) 

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "QRD" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "QRD" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

SKYTUNEUP (2017)

SKYTUNEUP: THE ULTIMATE PLATFORM TO OPTIMIZE AND SECURE THE USE OF PUBLIC CLOUD TO ORGANIZATIONS

Read More  

VoLTE-DM (2017)

VoLTE device management platform: enabler for the transition to full-LTE mobile networks and more efficient use of the scarce radio spectrum

Read More  

Piql-GO (2018)

Ultra-secure data storage - and long-term preservation of digital and analogue data

Read More